← Eichor
Study identifier: NCT07152106 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Amniotic Fluid & the Preterm Gut

Condition: Chorioamnionitis · Chorioamnionitis Affecting Fetus or Newborn · Necrotizing Enterocolitis of Newborn  ·  Sponsor: Maxima Medical Center

PhaseN/A
Planned participants275
Who can joinFemale, 16 Years to no upper limit
Healthy volunteersYes

About this study

Background: Necrotizing enterocolitis (NEC) and sepsis in preterm infants have been linked to intestinal immaturity and preclinical gut microbiota alterations. An important yet understudied contributor in the development of the gastrointestinal tract (GIT) is amniotic fluid (AF). Knowledge is lacking on the critical shifts that may occur in AF in extremely preterm birth. The aim of the current study is to assess the composition of AF using advanced biomedical techniques. Secondary objectives are to assess AF profiles of infants with chorioamnionitis (CAM) and/or fetal growth restriction (FGR), assess key metabolites across gestation, correlate AF profiles with neonatal outcomes, and explore associations with early gut microbiota. Methods: ln this multicenter, prospective, cohort study, AF (\~5 mL) will be collected from obstetric patients delivering their infants extremely preterm (gestational age (GA) 24+0/7-27+6/7 weeks, n=125), either during vaginal delivery or cesarean section (CS). Additionally, AF samples will be collected from a reference group (n=150), including early midtrimester (GA \<23+/7 weeks), very early and moderate to late preterm (GA 28+0/6-36+6/7 weeks), and full-term pregnancies (GA 37+0/7-41+6/7 weeks). Thorough characterization of AF will be conducted, including microbial profiling and metabolomics. Microbiota profiling of neonatal fecal samples will be conducted to assess the association between AF and early neonatal gut colonization patterns. Discu…

This description comes directly from the study's public registry record.

Talk to the study team

Mirjam M. van Weissenbruch  ·  020 566 9111  ·  m.vanweissenbruch@amsterdamumc.nl

Hendrik Niemarkt, dr

Always discuss trial participation with your own doctor first.

Locations (2)

Amsterdam UMCAmsterdam, NetherlandsRecruiting
Máxima Medical CenterVeldhoven, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07152106